CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS)

Flora Tassone, John Adams, Elizabeth M. Berry-Kravis, Susannah S. Cohen, Alfredo Brusco, Maureen A. Leehey, Lexin Li, Randi J Hagerman, Paul J Hagerman

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurological disorder among carriers of premutation CGG-repeat expansions within the FMR1 gene. Principal features of FXTAS include progressive action tremor and gait ataxia, with associated features of parkinsonism, peripheral neuropathy, dysautonomia, and cognitive decline. Although both clinical and neuropathologic features of FXTAS are known to be highly associated with CGG repeat length, the relationship between repeat length and age-of-onset is not known. To address this issue, the ages of onset of action tremor and gait ataxia were documented by history for 93 male carriers. For this cohort, the mean ages of onset were 62.6 ± 8.1 years (range, 39-78 years) for tremor, and 63.6 ± 7.3 years (range, 47-78 years) for ataxia; the mean CGG repeat number was 88.5 ± 14 (range, 60-133). Analysis of the relationship between clinical onset and molecular measures revealed significant correlations between CGG repeat number and onset of both tremor (P = 0.001) and ataxia (P = 0.002), as well as overall onset (P < 0.0001). Our findings indicate that the CGG repeat number is a potential predictor of the age of onset of core motor features of FXTAS.

Original languageEnglish (US)
Pages (from-to)566-569
Number of pages4
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume144
Issue number4
DOIs
StatePublished - Jun 5 2007

Fingerprint

Tremor
Age of Onset
Gait Ataxia
Ataxia
Primary Dysautonomias
Parkinsonian Disorders
Peripheral Nervous System Diseases
Nervous System Diseases
History
Fragile X Tremor Ataxia Syndrome
Genes

Keywords

  • Ataxia
  • Dementia
  • Neurodegeneration
  • Parkinson
  • RNA toxicity

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Cite this

CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). / Tassone, Flora; Adams, John; Berry-Kravis, Elizabeth M.; Cohen, Susannah S.; Brusco, Alfredo; Leehey, Maureen A.; Li, Lexin; Hagerman, Randi J; Hagerman, Paul J.

In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 144, No. 4, 05.06.2007, p. 566-569.

Research output: Contribution to journalArticle

Tassone, Flora ; Adams, John ; Berry-Kravis, Elizabeth M. ; Cohen, Susannah S. ; Brusco, Alfredo ; Leehey, Maureen A. ; Li, Lexin ; Hagerman, Randi J ; Hagerman, Paul J. / CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 2007 ; Vol. 144, No. 4. pp. 566-569.
@article{f28cdfd1a4604823b6b6bb2f59066225,
title = "CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS)",
abstract = "Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurological disorder among carriers of premutation CGG-repeat expansions within the FMR1 gene. Principal features of FXTAS include progressive action tremor and gait ataxia, with associated features of parkinsonism, peripheral neuropathy, dysautonomia, and cognitive decline. Although both clinical and neuropathologic features of FXTAS are known to be highly associated with CGG repeat length, the relationship between repeat length and age-of-onset is not known. To address this issue, the ages of onset of action tremor and gait ataxia were documented by history for 93 male carriers. For this cohort, the mean ages of onset were 62.6 ± 8.1 years (range, 39-78 years) for tremor, and 63.6 ± 7.3 years (range, 47-78 years) for ataxia; the mean CGG repeat number was 88.5 ± 14 (range, 60-133). Analysis of the relationship between clinical onset and molecular measures revealed significant correlations between CGG repeat number and onset of both tremor (P = 0.001) and ataxia (P = 0.002), as well as overall onset (P < 0.0001). Our findings indicate that the CGG repeat number is a potential predictor of the age of onset of core motor features of FXTAS.",
keywords = "Ataxia, Dementia, Neurodegeneration, Parkinson, RNA toxicity",
author = "Flora Tassone and John Adams and Berry-Kravis, {Elizabeth M.} and Cohen, {Susannah S.} and Alfredo Brusco and Leehey, {Maureen A.} and Lexin Li and Hagerman, {Randi J} and Hagerman, {Paul J}",
year = "2007",
month = "6",
day = "5",
doi = "10.1002/ajmg.b.30482",
language = "English (US)",
volume = "144",
pages = "566--569",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS)

AU - Tassone, Flora

AU - Adams, John

AU - Berry-Kravis, Elizabeth M.

AU - Cohen, Susannah S.

AU - Brusco, Alfredo

AU - Leehey, Maureen A.

AU - Li, Lexin

AU - Hagerman, Randi J

AU - Hagerman, Paul J

PY - 2007/6/5

Y1 - 2007/6/5

N2 - Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurological disorder among carriers of premutation CGG-repeat expansions within the FMR1 gene. Principal features of FXTAS include progressive action tremor and gait ataxia, with associated features of parkinsonism, peripheral neuropathy, dysautonomia, and cognitive decline. Although both clinical and neuropathologic features of FXTAS are known to be highly associated with CGG repeat length, the relationship between repeat length and age-of-onset is not known. To address this issue, the ages of onset of action tremor and gait ataxia were documented by history for 93 male carriers. For this cohort, the mean ages of onset were 62.6 ± 8.1 years (range, 39-78 years) for tremor, and 63.6 ± 7.3 years (range, 47-78 years) for ataxia; the mean CGG repeat number was 88.5 ± 14 (range, 60-133). Analysis of the relationship between clinical onset and molecular measures revealed significant correlations between CGG repeat number and onset of both tremor (P = 0.001) and ataxia (P = 0.002), as well as overall onset (P < 0.0001). Our findings indicate that the CGG repeat number is a potential predictor of the age of onset of core motor features of FXTAS.

AB - Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurological disorder among carriers of premutation CGG-repeat expansions within the FMR1 gene. Principal features of FXTAS include progressive action tremor and gait ataxia, with associated features of parkinsonism, peripheral neuropathy, dysautonomia, and cognitive decline. Although both clinical and neuropathologic features of FXTAS are known to be highly associated with CGG repeat length, the relationship between repeat length and age-of-onset is not known. To address this issue, the ages of onset of action tremor and gait ataxia were documented by history for 93 male carriers. For this cohort, the mean ages of onset were 62.6 ± 8.1 years (range, 39-78 years) for tremor, and 63.6 ± 7.3 years (range, 47-78 years) for ataxia; the mean CGG repeat number was 88.5 ± 14 (range, 60-133). Analysis of the relationship between clinical onset and molecular measures revealed significant correlations between CGG repeat number and onset of both tremor (P = 0.001) and ataxia (P = 0.002), as well as overall onset (P < 0.0001). Our findings indicate that the CGG repeat number is a potential predictor of the age of onset of core motor features of FXTAS.

KW - Ataxia

KW - Dementia

KW - Neurodegeneration

KW - Parkinson

KW - RNA toxicity

UR - http://www.scopus.com/inward/record.url?scp=34250869612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250869612&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.30482

DO - 10.1002/ajmg.b.30482

M3 - Article

C2 - 17427188

AN - SCOPUS:34250869612

VL - 144

SP - 566

EP - 569

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 4

ER -